72 related articles for article (PubMed ID: 10445845)
1. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice.
Honda H; Harada K; Komuro I; Terasaki F; Ueno H; Tanaka Y; Kawamura K; Yazaki Y; Hirai H
Oncogene; 1999 Jul; 18(26):3821-30. PubMed ID: 10445845
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
[TBL] [Abstract][Full Text] [Related]
3. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy.
Takeishi Y; Ping P; Bolli R; Kirkpatrick DL; Hoit BD; Walsh RA
Circ Res; 2000 Jun; 86(12):1218-23. PubMed ID: 10864911
[TBL] [Abstract][Full Text] [Related]
4. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
[TBL] [Abstract][Full Text] [Related]
5. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
[TBL] [Abstract][Full Text] [Related]
6. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.
Isoda K; Kamezawa Y; Tada N; Sato M; Ohsuzu F
J Card Fail; 2001 Dec; 7(4):355-64. PubMed ID: 11782860
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
8. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
[TBL] [Abstract][Full Text] [Related]
9. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG
Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
[TBL] [Abstract][Full Text] [Related]
12. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
13. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.
Shende P; Plaisance I; Morandi C; Pellieux C; Berthonneche C; Zorzato F; Krishnan J; Lerch R; Hall MN; Rüegg MA; Pedrazzini T; Brink M
Circulation; 2011 Mar; 123(10):1073-82. PubMed ID: 21357822
[TBL] [Abstract][Full Text] [Related]
14. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
15. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
17. Increased tyrosine-phosphorylation of 55KDa proteins in beta-actin/Tec transgenic mice.
Honda H; Mano H; Katsuki M; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1995 Jan; 206(1):287-93. PubMed ID: 7529498
[TBL] [Abstract][Full Text] [Related]
18. HSP75 protects against cardiac hypertrophy and fibrosis.
Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
